Akums Drugs & Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹1,166.63 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.76 per cent from ₹1,157.87 crore. This corresponds to a year-on-year *(YoY) growth of 13.93 per cent.
Operating Profit
Operating Profit stands at ₹174.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 16.51 per cent from ₹149.93 crore. This corresponds to a year-on-year *(YoY) growth of 35.44 per cent.
PBDT
PBDT stands at ₹180.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.76 per cent from ₹161.33 crore. This corresponds to a year-on-year *(YoY) growth of 36.01 per cent.
Profit Before Tax
Profit Before Tax stands at ₹139.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.88 per cent from ₹121.21 crore. This corresponds to a year-on-year *(YoY) growth of 45.57 per cent.
Net Profit
Net Profit stands at ₹100.98 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.15 per cent from ₹81.34 crore. This represents a 56.10 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Akums Drugs & Pharmaceuticals Ltd News
Akums Drugs & Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Akums Drugs & Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Akums Drugs & Pharmaceuticals Ltd Research Reports
Akums Drugs & Pharmaceuticals Ltd Financial Reports
Akums Drugs & Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Akums Drugs | -0.78% | -1.05% | 10.01% | 44.62% | 55.34% | 54.49% |
| Marksans Pharma | -1.61% | 7.62% | 22.28% | 50.26% | 82.90% | 79.73% |
| Jubilant Pharmo | 0.03% | -2.69% | -15.69% | -14.80% | -0.63% | -20.19% |
| Corona Remedies | 0.05% | 0.04% | 3.47% | 22.08% | 39.08% | 47.03% |
| Blue Jet Health | 2.21% | 2.03% | 2.92% | 38.76% | 70.77% | -21.84% |
| Viyash Scientific | 0.85% | -4.43% | -3.80% | 1.01% | 17.40% | 43.99% |
| Sanofi Consumer | -0.55% | -2.80% | -4.19% | -10.19% | 7.37% | -17.25% |
Company Info
Company Information
ED / MD / Promoter : SANJEEV JAIN
ED / MD / Promoter : SANDEEP JAIN
Whole-time Director : Sanjay Sinha
Independent Non Exe. Director : Kewal Handa
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : SATWINDER SINGH
Non-Exec & Non-Independent Dir : SUNIL KUMAR THAKUR
Independent Non Exe. Director : Anil Kumar Arvindlal Amin
Company Sec. & Compli. Officer : DHARAMVIR MALIK